TransCode Therapeutics (RNAZ)
Nasdaq • RNAZ • US89357L5012
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 2.9% of free float sold short, 1.8 days to cover, cost to borrow 9.59%. Sign up for live short interest data.
Market Cap
23.7m USD | # 10270 in US
Volume
53.71k shares | 104.56k USD
Shares Outstanding
16.93m
Free Float Shares
12.72% | 2.15m
